Novo Nordisk Lawsuits Target Semaglutide Copies
Danish pharmaceutical giant Novo Nordisk has intensified its legal battle against the sale of unapproved versions of semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drugs
Medication management for seniors: Making sure the cure isn’t worse than the disease
According to recent data collected by Health Canada, seniors represent 17% of the population but are more than 40% of prescription users. Read more...